Drug profile · INN
indium in-111 pentetate disodium
MPI INDIUM DTPA IN 111
indium in-111 pentetate disodium (MPI INDIUM DTPA IN 111) is a diagnostic agent. Route of administration: intrathecal. Current US regulatory status: approved.
Drug details — indium in-111 pentetate disodium
- US status
- approved
- Class
- —
- Route
- INTRATHECAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
indium in-111 pentetate disodium (MPI INDIUM DTPA IN 111) is a diagnostic agent. Route of administration: intrathecal. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is indium in-111 pentetate disodium?
indium in-111 pentetate disodium (MPI INDIUM DTPA IN 111) is a diagnostic agent. Route of administration: intrathecal. Current US regulatory status: approved.
What is the brand name for indium in-111 pentetate disodium?
MPI INDIUM DTPA IN 111 is a marketed brand name for indium in-111 pentetate disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of indium in-111 pentetate disodium?
indium in-111 pentetate disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.